|
Clostridium difficile outbreaks: prevention and treatment strategiesDOI: http://dx.doi.org/10.2147/RMHP.S13053 Keywords: antibiotic, antimicrobial, infectious colitis, pseudomembranous colitis, nosocomial, iatrogenic, toxin, Clostridium difficile A Letter to the Editor has been received and published for this article. Abstract: stridium difficile outbreaks: prevention and treatment strategies Review (2990) Total Article Views Authors: Martinez FJ, Leffler DA, Kelly CP Published Date July 2012 Volume 2012:5 Pages 55 - 64 DOI: http://dx.doi.org/10.2147/RMHP.S13053 Received: 23 June 2010 Accepted: 30 September 2010 Published: 03 July 2012 Fernando J Martinez,1 Daniel A Leffler,2 Ciaran P Kelly2 1Division of Gastroenterology, Department of Medicine, University of Miami, Miller School of Medicine, Miami, FL, USA; 2Department of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA Abstract: The incidence and severity of Clostridium difficile infection (CDI) have increased dramatically over the past decade. Its treatment, however, has largely remained the same with the exception of oral vancomycin use as a first-line agent in severe disease. From 1999 to 2004, 20,642 deaths were attributed to CDI in the United States, almost 7 times the rate of all other intestinal infections combined. Worldwide, several major CDI outbreaks have occurred, and many of these were associated with the NAP1 strain. This ‘epidemic’ strain has contributed to the rising incidence and mortality of CDI. The purpose of this article is to review the current management, treatment, infection control, and prevention strategies that are needed to combat this increasingly morbid disease.
|